Dr. Jason A. Diaz, MD

Dr. Diaz practices at Ear, Nose & Throat Surgery Center of Utah in Salt Lake City, Utah.

Dr. Diaz's NPI, 1417144353, was assigned on September 25, 2007. Dr. Diaz graduated from Medical College of Georgia in 2003. Dr. Diaz's Missouri license number on file is 2009016631.

Dr. Diaz's primary practice is Ear, Nose & Throat Surgery Center of Utah, at 22 S 900 E Ste 2, Salt Lake City, UT 84102. The practice phone is (801) 328-2522.

Dr. Diaz's primary practice is Ear, Nose & Throat Surgery Center of Utah in Salt Lake City, Utah. Dr. Diaz is also affiliated with St. Mark's Hospital. The medical group on file is Ear, Nose and Throat Center of Utah. Dmand AI also links Dr. Diaz to 4 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Diaz's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Diaz practices, 7 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Diaz's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Diaz is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Diaz's licenses on file in 3 states: Missouri, Utah and Pennsylvania.

Dmand AI lists larynx and vocal cord disease and thyroid surgery among the conditions Dr. Diaz treats.

CMS data shows 186 Medicare services from Dr. Diaz across 7 procedure codes in 2024, for 76 Medicare patients. Medicare paid $20,856 for them. Every service was in an office.

CMS counts 76 Medicare patients who saw Dr. Diaz in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Diaz's median patient age at 58, with 66% women.

In 2024, Dr. Diaz wrote 167 Medicare Part D claims for 55 patients. 90% of them were for generic drugs. CMS names the drug for 108 of them, across 4 drugs with 11 or more claims each, at $312 in total drug cost. In 2023, CMS named 114 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Diaz for performance year 2024, reported through an alternative payment model (APM). Dr. Diaz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Diaz, published from 2008 to 2023. 2015 was the busiest year, with 3. The most frequent topics are Carcinoma, Squamous Cell, Plastic Surgery Procedures and Atlanto-Axial Joint. Dr. Diaz has published most often in Head Neck. Dr. Diaz's most frequent co-authors are Brian Nussenbaum, MD, Jason Thomas Rich, MD and Evan Michael Graboyes, MD.

Dmand AI links Dr. Diaz to 2 clinical trials. Conditions studied include Mouth Neoplasms, Oropharyngeal Neoplasms and Mouth Diseases. Washington University School of Medicine sponsors the most, 2.

CMS Open Payments shows 25 general payments to Dr. Diaz from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Intersect ENT, Inc. paid the most, $779.

Dmand AI lists 3 awards for Dr. Diaz, most recently CMS Stage 1 EHR in 2012. Dr. Diaz serves on Intermountain Medical Center - Department of Surgery Executive Committee, American Academy of Otolaryngology - Head & Neck Surgery - Microvascular Committee and Jordan Valley Medical Center - Cancer Committee.

Dr. Diaz graduated from Medical College of Georgia in 2003. Dr. Diaz is a member of NHS, ACS and American Head & Neck Society.

Dr. Diaz is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.